(Q37052200)

17 August 2017

1 reference

title

An overview of the GAGE cancer/testis antigen family with the inclusion of newly identified members (English)

1 reference

17 August 2017

M F Gjerstorff

1

1 reference

17 August 2017

H J Ditzel

series ordinal

2

1 reference

17 August 2017

publication date

7 January 2008

1 reference

17 August 2017

1 reference

17 August 2017

volume

71

1 reference

17 August 2017

issue

3

1 reference

17 August 2017

page(s)

187-192

1 reference

The testis in immune privilege

17 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2007.00997.X

Cancer/testis antigens, gametogenesis and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2007.00997.X

HLA expression on immature and mature human germ cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2007.00997.X

Cancer/testis antigens: structural and immunobiological properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2007.00997.X

Tumor-specific shared antigenic peptides recognized by human T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2007.00997.X

Vaccination with an NY-ESO-1 peptide of HLA class I/II specificities induces integrated humoral and T cell responses in ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2007.00997.X

Vaccination with mage-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2007.00997.X

Recombinant vaccinia/fowlpox NY-ESO-1 vaccines induce both humoral and cellular NY-ESO-1-specific immune responses in cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2007.00997.X

Recombinant NY-ESO-1 protein with ISCOMATRIX adjuvant induces broad integrated antibody and CD4+ and CD8+ T cell responses in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2007.00997.X

Rapid evolution of cancer/testis genes on the X chromosome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2007.00997.X

A new family of genes coding for an antigen recognized by autologous cytolytic T lymphocytes on a human melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2007.00997.X

Transfection and expression of a gene coding for a human melanoma antigen recognized by autologous cytolytic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2007.00997.X

The DNA sequence of the human X chromosome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2007.00997.X

Tumor-specific antigens in cutaneous T-cell lymphoma: expression and sero-reactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2007.00997.X

mRNA expression of tumor-associated antigens in melanoma tissues and cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2007.00997.X

Alu repeats and human genomic diversity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2007.00997.X

The XAGE family of cancer/testis-associated genes: alignment and expression profile in normal tissues, melanoma lesions and Ewing's sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2007.00997.X

Restriction of GAGE protein expression to subpopulations of cancer cells is independent of genotype and may limit the use of GAGE proteins as targets for cancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2007.00997.X

MAGE-A1, GAGE and NY-ESO-1 cancer/testis antigen expression during human gonadal development

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2007.00997.X

Expression of GAGE family proteins in malignant melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2007.00997.X

Analysis of cancer/testis antigens in sporadic medullary thyroid carcinoma: expression and humoral response to NY-ESO-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2007.00997.X

Prospective study on the expression of cancer testis genes and antibody responses in 100 consecutive patients with primary breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2007.00997.X

MAGE, BAGE and GAGE: tumour antigen expression in benign and malignant ovarian tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2007.00997.X

Cancer testis antigens expression in mesothelioma: role of DNA methylation and bioimmunotherapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2007.00997.X

Acetylation-induced transcription is required for active DNA demethylation in methylation-silenced genes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2007.00997.X

A monoclonal cytolytic T-lymphocyte response observed in a melanoma patient vaccinated with a tumor-specific antigenic peptide encoded by gene MAGE-3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2007.00997.X

Cytolytic T-cell responses of cancer patients vaccinated with a MAGE antigen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2007.00997.X

Induction of primary NY-ESO-1 immunity: CD8+ T lymphocyte and antibody responses in peptide-vaccinated patients with NY-ESO-1+ cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2007.00997.X

Monitoring CD8 T cell responses to NY-ESO-1: correlation of humoral and cellular immune responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0039.2007.00997.X

10.1111/J.1399-0039.2007.00997.X

21 January 2018

Identifiers

DOI

1 reference

17 August 2017

1 reference